...
search icon
aeon-img

AEON Biopharma, Inc., Common Stock

AEON

ASQ

$0.9663

+$0.03

(3.19%)

1D
Industry: Biotechnology Sector: Health Care

Analyst Forecast

Price Chart

Key Metrics

Market Cap info-icon
This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.
$6.67M
P/E Ratio info-icon
This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.
0.0029
Volume info-icon
This is the total number of shares traded during the most recent trading day.
793.02K
Avg Volume info-icon
This is the average number of shares traded during the most recent 30 days.
0
Dividend Yield info-icon
This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).
0.00%
Beta info-icon
This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.
0.57
52-week Range info-icon
This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).
$0.38 L
$239.76 H
$0.9663

About AEON Biopharma, Inc., Common Stock

AEON Biopharma, Inc., a clinical stage biopharmaceutical company, focuses on developing botulinum toxins. It develops ABP-450 (prabotulinumtoxinA) injection for debilitating medical conditions, which completed Phase 2 study for the treatment of cervical dystonia and has an ongoing Phase 2 study for the treatment of chronic and episodic migraine, as well as develops ABP-450 for the treatment of gastroparesis and post-traumatic stress disorder. The company has license agreements Daewoong Pharmaceutical Co., LTD., and Viatris Inc. The company is based in Irvine, California. more

Industry: BiotechnologySector: Health Care

Returns

Time FrameAEONSectorS&P500
1-Week Return47.64%1.85%1.23%
1-Month Return96.4%-0.15%3.45%
3-Month Return38.04%-7.06%8.43%
6-Month Return-98.51%-4.5%-0.74%
1-Year Return-99.09%-7.25%12.33%
3-Year Return-99.86%11.55%60.94%
5-Year Return-99.86%39.99%100.63%

Financials

Dec '19Dec '20Dec '21Dec '22Dec '245YR TREND
Total Revenue3.36M2.52M---[{"date":"2019-12-31","value":100,"profit":true},{"date":"2020-12-31","value":75.01,"profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Cost of Revenue1.00K----[{"date":"2019-12-31","value":100,"profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Gross Profit3.36M2.52M---[{"date":"2019-12-31","value":100,"profit":true},{"date":"2020-12-31","value":75.03,"profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Gross Margin99.97%100.00%---[{"date":"2019-12-31","value":99.97,"profit":true},{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Operating Expenses51.73M18.91M36.88M48.43M(72.98M)[{"date":"2019-12-31","value":100,"profit":true},{"date":"2020-12-31","value":36.55,"profit":true},{"date":"2021-12-31","value":71.3,"profit":true},{"date":"2022-12-31","value":93.63,"profit":true},{"date":"2024-12-31","value":-141.1,"profit":false}]
Operating Income(53.97M)(16.39M)(65.85M)(48.43M)72.98M[{"date":"2019-12-31","value":-73.94,"profit":false},{"date":"2020-12-31","value":-22.45,"profit":false},{"date":"2021-12-31","value":-90.22,"profit":false},{"date":"2022-12-31","value":-66.35,"profit":false},{"date":"2024-12-31","value":100,"profit":true}]
Total Non-Operating Income/Expense192.89M(16.54M)---[{"date":"2019-12-31","value":100,"profit":true},{"date":"2020-12-31","value":-8.58,"profit":false},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Pre-Tax Income145.67M(32.91M)(55.64M)(52.56M)42.01M[{"date":"2019-12-31","value":100,"profit":true},{"date":"2020-12-31","value":-22.59,"profit":false},{"date":"2021-12-31","value":-38.19,"profit":false},{"date":"2022-12-31","value":-36.08,"profit":false},{"date":"2024-12-31","value":28.84,"profit":true}]
Income Taxes(14.64M)15.00K28.97M(160.49K)-[{"date":"2019-12-31","value":-50.56,"profit":false},{"date":"2020-12-31","value":0.05,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":-0.55,"profit":false},{"date":"2024-12-31","value":"-","profit":true}]
Income After Taxes160.31M(32.93M)---[{"date":"2019-12-31","value":100,"profit":true},{"date":"2020-12-31","value":-20.54,"profit":false},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Income From Continuous Operations160.31M(32.91M)(55.64M)(52.56M)42.01M[{"date":"2019-12-31","value":100,"profit":true},{"date":"2020-12-31","value":-20.53,"profit":false},{"date":"2021-12-31","value":-34.7,"profit":false},{"date":"2022-12-31","value":-32.78,"profit":false},{"date":"2024-12-31","value":26.2,"profit":true}]
Income From Discontinued Operations-----[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Net Income172.92M(32.91M)(55.64M)(52.56M)42.01M[{"date":"2019-12-31","value":100,"profit":true},{"date":"2020-12-31","value":-19.03,"profit":false},{"date":"2021-12-31","value":-32.17,"profit":false},{"date":"2022-12-31","value":-30.39,"profit":false},{"date":"2024-12-31","value":24.29,"profit":true}]
EPS (Diluted)--(8.61)13.31(2.72)[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":-64.74,"profit":false},{"date":"2022-12-31","value":100,"profit":true},{"date":"2024-12-31","value":-20.41,"profit":false}]

Ratios

Liquidity

These ratios help you determine the liquidity of the company. Higher is better.

AEON
Current Ratio 1.43

Asset Efficiency

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

AEON
ROA (LTM) -158.88%
ROE (LTM) 0.00%

Liabilities

These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

AEON
Debt Ratio Lower is generally better. Negative is bad. 1.82
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. -0.82

Valuation

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

AEON
Trailing PE 0.00
Forward PE 1.16
P/S (TTM) 97.16
P/B 0.00
Price/FCF NM
EV/R 201.68
EV/Ebitda NM

FAQs

What is AEON Biopharma, Inc. share price today?

AEON Biopharma, Inc. (AEON) share price today is $0.9663

Can Indians buy AEON Biopharma, Inc. shares?

Yes, Indians can buy shares of AEON Biopharma, Inc. (AEON) on Vested. To buy AEON Biopharma, Inc. from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in AEON stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of AEON Biopharma, Inc. be purchased?

Yes, you can purchase fractional shares of AEON Biopharma, Inc. (AEON) via the Vested app. You can start investing in AEON Biopharma, Inc. (AEON) with a minimum investment of $1.

How to invest in AEON Biopharma, Inc. shares from India?

You can invest in shares of AEON Biopharma, Inc. (AEON) via Vested in three simple steps:

  • Click on Sign Up or Invest in AEON stock at the top of this page
  • Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
  • Transfer USD funds to your US Brokerage account and start investing in AEON Biopharma, Inc. shares
What is AEON Biopharma, Inc. 52-week high and low stock price?

The 52-week high price of AEON Biopharma, Inc. (AEON) is $239.76. The 52-week low price of AEON Biopharma, Inc. (AEON) is $0.38.

What is AEON Biopharma, Inc. price-to-earnings (P/E) ratio?

The price-to-earnings (P/E) ratio of AEON Biopharma, Inc. (AEON) is 0.0029

What is AEON Biopharma, Inc. price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of AEON Biopharma, Inc. (AEON) is 0.00

What is the Market Cap of AEON Biopharma, Inc.?

The market capitalization of AEON Biopharma, Inc. (AEON) is $6.67M

What is AEON Biopharma, Inc.’s stock symbol?

The stock symbol (or ticker) of AEON Biopharma, Inc. is AEON

Signup to access all features and start your US investing journey!

  • Open your account in minutes
  • Take your portfolio global, starting at just $1
Get started

Add ticker to compare

Scroll to Top